` Comparison: TBPH vs NOVN - Alpha Spread

TBPH
vs
NOVN

Over the past 12 months, TBPH has significantly outperformed NOVN, delivering a return of +110% compared to the NOVN's +34% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
TBPH
NOVN
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

TBPH Intrinsic Value
11.65 USD
Overvaluation 39%
Intrinsic Value
Price
NOVN Intrinsic Value
107.11 CHF
Overvaluation 17%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Theravance Biopharma Inc
NASDAQ:TBPH
19.06 USD
Novartis AG
SIX:NOVN
129.6 CHF
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
TBPH, NOVN

TBPH
NOVN
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Theravance Biopharma Inc
Revenue
Novartis AG
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
TBPH, NOVN

TBPH
NOVN
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Theravance Biopharma Inc
NASDAQ:TBPH
Novartis AG
SIX:NOVN
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

TBPH
0%
NOVN
75.8%

Operating Margin

TBPH
-40.9%
NOVN
33.2%

Net Margin

TBPH
36.5%
NOVN
24.8%

FCF Margin

TBPH
303.1%
NOVN
27.1%

ROE

TBPH
14%
NOVN
31%

ROA

TBPH
7.6%
NOVN
13.1%

ROIC

TBPH
-11.8%
NOVN
17.8%

ROCE

TBPH
-9.2%
NOVN
23.8%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
TBPH, NOVN

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
TBPH, NOVN

Loading
TBPH
NOVN
Difference
www.alphaspread.com

Performance By Year
TBPH, NOVN

Loading
TBPH
NOVN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare TBPH to other stocks
LLY
Eli Lilly and Co
More expensive
vs TBPH
JNJ
Johnson & Johnson
Cheaper
vs TBPH
ROG
Roche Holding AG
Cheaper
vs TBPH
AZN
AstraZeneca PLC
More expensive
vs TBPH
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett